Pomerantz LLP is investigating claims on behalf of investors of Replimune Group, Inc. (“Replimune” or the “Company”) (NASDAQ: REPL). Such investors are ...

Replimune Group, Inc. (Nasdaq: REPL), a clinical-stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced the outcome of today's ...

Apple has released Safari Technology Preview 248, the latest version of its developer preview web browser. The preview ...

Google released LiteRT.js, a JavaScript binding of LiteRT. LiteRT is Google’s on-device inference library, previously called TensorFlow Lite. LiteRT.js runs .tflite models directly inside the browser.

Stock futures cautious on Monday as investors reacted to a breakdown in peace talks between the U.S. and Iran over the weekend. Tensions spiked after President Donald Trump threatened a military ...

News is breaking today that Replimune Group, Inc.'s (REPL) Biologics License Application ("BLA") requesting approval for its drug candidate RP1 (vusolimogene oderparepvec) in the indication of anti-PD ...

FDA issued a second complete response letter denying approval for Replimune’s RP1 melanoma immunotherapy The treatment was under review for use with Bristol Myers Squibb’s (BMY) Opdivo Regulatory ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

We're all tired of spending money on stuff that breaks. Whether it's a tool that wears out instantly or a pair of pants that gets a hole too soon, it seems like more things in this world should be ...

The JavaScript innovation train is really picking up momentum lately, driven—as always—by the creativity of the JavaScript developer community. The emerging local-first SQL datastores crystalize ideas ...